piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair
出版年份 2021 全文链接
标题
piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair
作者
关键词
-
出版物
Communications Biology
Volume 4, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-11-19
DOI
10.1038/s42003-021-02844-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- piRNAs: biogenesis and their potential roles in cancer
- (2020) Binghong Guo et al. CANCER AND METASTASIS REVIEWS
- Mechanisms of Multidrug Resistance in Cancer Chemotherapy
- (2020) Karol Bukowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miRNA‐765 mediates multidrug resistance via targeting BATF2 in gastric cancer cells
- (2020) Wan Lin et al. FEBS Open Bio
- Inhibiting RRM2 to enhance the anticancer activity of chemotherapy
- (2020) Yaqiong Zhan et al. BIOMEDICINE & PHARMACOTHERAPY
- Co-expression Network Analysis Identifies Four Hub Genes Associated With Prognosis in Soft Tissue Sarcoma
- (2019) Zhenhua Zhu et al. Frontiers in Genetics
- MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine based chemotherapy
- (2019) Huimin Lu et al. BIOSCIENCE REPORTS
- A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
- (2019) Ying Z. Mazzu et al. CLINICAL CANCER RESEARCH
- Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it
- (2019) Himanshu Verma et al. DRUG METABOLISM REVIEWS
- Noncoding RNAs in cancer therapy resistance and targeted drug development
- (2019) Wen-Tao Wang et al. Journal of Hematology & Oncology
- PIWI‐interacting RNA 39980 promotes tumor progression and reduces drug sensitivity in neuroblastoma cells
- (2019) Jyoti Roy et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Emerging roles of piRNAs in cancer: challenges and prospects
- (2019) Ye Cheng et al. Aging-US
- piR‐39980 promotes cell proliferation, migration and invasion, and inhibits apoptosis via repression of SERPINB1 in human osteosarcoma
- (2019) Basudeb Das et al. BIOLOGY OF THE CELL
- Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
- (2019) Xu Wang et al. Frontiers in Pharmacology
- Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer
- (2018) Wenhao Weng et al. Molecular Cancer
- siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
- (2018) Shuquan Zheng et al. Molecular Therapy-Nucleic Acids
- Tumor suppressive activity of PIWI-interacting RNA in human fibrosarcoma mediated through repression of RRM2
- (2018) Basudeb Das et al. MOLECULAR CARCINOGENESIS
- MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF
- (2017) B Li et al. ONCOGENE
- The emergence of piRNAs against transposon invasion to preserve mammalian genome integrity
- (2017) Christina Ernst et al. Nature Communications
- Identification and characterization of RASSF1C piRNA target genes in lung cancer cells
- (2017) Mark E. Reeves et al. Oncotarget
- Noncoding RNA in drug resistant sarcoma
- (2017) Xiaoyang Li et al. Oncotarget
- Regulation of multidrug resistance by microRNAs in anti-cancer therapy
- (2017) Xin An et al. Acta Pharmaceutica Sinica B
- Chemotherapy for soft tissue sarcoma
- (2016) Ravin Ratan et al. CANCER
- piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4
- (2016) Dan Li et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy
- (2016) Fien Hoefkens et al. Radiation Oncology
- PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma
- (2016) Anna Cordeiro et al. Oncotarget
- Stem-Loop RT-qPCR as an Efficient Tool for the Detection and Quantification of Small RNAs in Giardia lamblia
- (2016) Jaime Marcial-Quino et al. Genes
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
- (2014) Ian Judson et al. LANCET ONCOLOGY
- piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma
- (2014) H Yan et al. LEUKEMIA
- OpenComet: An automated tool for comet assay image analysis
- (2014) Benjamin M. Gyori et al. Redox Biology
- Reduced Intracellular Drug Accumulation in Drug-Resistant Leukemia Cells is Not Only Solely Due to MDR-Mediated Efflux but also to Decreased Uptake
- (2014) Angela Oliveira Pisco et al. Frontiers in Oncology
- Molecular mechanisms of radiation resistance in doxorubicin-resistant breast adenocarcinoma cells
- (2013) LIDIA LUZHNA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Bleach gel: A simple agarose gel for analyzing RNA quality
- (2012) Patrick S. Aranda et al. ELECTROPHORESIS
- Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line
- (2012) Shatha AbuHammad et al. GENOMICS
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model
- (2011) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells
- (2011) Jia Cheng et al. CANCER LETTERS
- Activation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heart
- (2011) Maria Volkova et al. CARDIOVASCULAR RESEARCH
- piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells
- (2011) Jia Cheng et al. CLINICA CHIMICA ACTA
- γH2AX: a sensitive molecular marker of DNA damage and repair
- (2010) L-J Mah et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search